For potential investors looking to establish a position in SCLN, the company is expected to post a profit of $0.18/share on revenue of $41.98 million for the second quarter. Given the fact that the company has surpassed analysts' estimates in the last four quarters, another earnings estimate beat of at least 15% would positively contribute to the company's growth. In terms of establishing a position at these levels, a small- to medium-sized position would be acceptable at current levels, and more shares should be added as earnings announcements approach.
http://seekingalpha.com/article/705781-3-promising-pharma-companies-projected-to-grow-5-times-faster-than-the-s-p-500?source=yahoo
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM